We are live on ! Find out more
EMG

ETF Managers Group Portfolio holdings

AUM $3.1B
1-Year Est. Return 17.12%
This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
AUM
$6.13B
AUM Growth
+$505M
Cap. Flow
+$205M
Cap. Flow %
3.34%
Top 10 Hldgs %
19.96%
Holding
831
New
162
Increased
239
Reduced
241
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 42.87%
2 Healthcare 15.14%
3 Materials 14.7%
4 Financials 7.38%
5 Consumer Staples 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
626
Arbutus Biopharma
ABUS
$1B
$90K ﹤0.01%
28,451
+2,442
+9% +$7.56K
HOOK
627
DELISTED
HOOKIPA Pharma
HOOK
$81K ﹤0.01%
879
-130
-13% -$17.3K
TLIS
628
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$81K ﹤0.01%
504
-21
-4% -$3.57K
CRMD icon
629
CorMedix
CRMD
$647M
$80K ﹤0.01%
11,235
+1,392
+14% +$11.1K
CODX
630
Co-Diagnostics
CODX
$8.45M
$75K ﹤0.01%
282
-7
-2% -$1.8K
XNET
631
Xunlei
XNET
$319M
$74K ﹤0.01%
16,226
+572
+4% +$2.92K
LNAI
632
Lunai Bioworks
LNAI
$10.7M
$72K ﹤0.01%
176
-3
-2% -$978
LHDX
633
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$67K ﹤0.01%
11,380
-15
-0.1% -$95
IMNM icon
634
Immunome
IMNM
$3.13B
$61K ﹤0.01%
3,471
+221
+7% +$4.88K
PHAS
635
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$52K ﹤0.01%
14,179
+5,184
+58% +$17.3K
CFRX
636
DELISTED
ContraFect Corporation
CFRX
$50K ﹤0.01%
145
+39
+37% +$12.8K
YCBD icon
637
cbdMD
YCBD
$5.6M
$48K ﹤0.01%
45
-50
-53% -$59.8K
ASMB icon
638
Assembly Biosciences
ASMB
$694M
$46K ﹤0.01%
987
+10
+1% +$495
ENZ
639
DELISTED
Enzo Biochem, Inc.
ENZ
$44K ﹤0.01%
14,225
-446
-3% -$1.4K
EVAX
640
Evaxion A/S
EVAX
$25.1M
$43K ﹤0.01%
113
-5
-4% -$1.68K
IMV
641
DELISTED
IMV Inc. Common Shares
IMV
$42K ﹤0.01%
1,979
-73
-4% -$1.86K
IFRX icon
642
InflaRx
IFRX
$329M
$38K ﹤0.01%
12,931
-395
-3% -$1.31K
EGIO
643
DELISTED
Edgio, Inc. Common Stock
EGIO
$38K ﹤0.01%
301
-22
-7% -$2.9K
ABTC
644
American Bitcoin Corp
ABTC
$560M
0
OGN icon
645
Organon & Co
OGN
$3.61B
$24K ﹤0.01%
+778
New +$25.6K
MARA icon
646
Marathon Digital Holdings
MARA
$4.12B
$6K ﹤0.01%
176
-24,691
-99% -$783K
ADP icon
647
Automatic Data Processing
ADP
$114B
-2,356
Closed -$443K
AFL icon
648
Aflac
AFL
$58.4B
-9,726
Closed -$504K
AJG icon
649
Arthur J. Gallagher & Co
AJG
$68.6B
-3,954
Closed -$497K
ALB icon
650
Albemarle
ALB
$16.2B
-5,707
Closed -$830K

Similar funds

ETF Managers Group's Q2 2021 Portfolio in Review

As of Q2 2021, ETF Managers Group held 831 positions worth $6.13B, up 9% from $5.63B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

ETF Managers Group deployed $205M of net new capital in Q2 2021, opening 162 new positions and adding to 239 existing holdings. Its largest new stake was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Hecla Mining, an estimated $43.6M trimmed.

  • ETF Managers Group's largest Q2 2021 buy was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
  • ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q2 2021, an estimated $79.6M increase.
  • ETF Managers Group's biggest Q2 2021 reduction was Hecla Mining, cutting an estimated $43.6M.
  • ETF Managers Group fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $187M.
  • ETF Managers Group's ten largest holdings make up 20% of its $6.13B portfolio in Q2 2021.
  • ETF Managers Group opened 162 new positions and closed 184 in Q2 2021.
  • ETF Managers Group's portfolio value rose 9% quarter-over-quarter to $6.13B.

Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.